TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
This Quarter Return
+3.73%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$3.11B
AUM Growth
+$3.11B
(+0.92%)
Cap. Flow
+$26.2M
Cap. Flow
% of AUM
0.84%
Top 10 Holdings %
Top 10 Hldgs %
33.83%
Holding
206
New
17
Increased
43
Reduced
39
Closed
34
Top Buys
| 1 |
Rallybio
RLYB
|
$37.6M |
| 2 |
Guardant Health
GH
|
$28.7M |
| 3 |
Idexx Laboratories
IDXX
|
$27.9M |
| 4 |
Amgen
AMGN
|
$23.7M |
| 5 |
AstraZeneca
AZN
|
$21.9M |
Top Sells
| 1 |
Elevance Health
ELV
|
$34.7M |
| 2 |
ResMed
RMD
|
$32.6M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$22.2M |
| 4 |
DexCom
DXCM
|
$21.8M |
| 5 |
Ascendis Pharma
ASND
|
$13.7M |
Sector Composition
| 1 | Healthcare | 96.51% |
| 2 | Real Estate | 2.72% |
| 3 | Industrials | 0.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Aurinia Pharmaceuticals
AUPH
$1.58B
| $5.6M | 0.18% |
252,821
-145,099
| -36% | -$3.21M |
|
102
Qiagen
QGEN
$10.1B
| $5.57M | 0.18% |
+101,713
| New | +$5.57M |
|
|
103
Elevance Health
ELV
$72.4B
| $5.46M | 0.18% |
14,644
-93,090
| -86% | -$34.7M |
|
|
VECT
104
DELISTED
VectivBio Holding AG Ordinary Shares
VECT
| $5.37M | 0.17% |
756,502
+611,502
| +422% | +$4.34M |
|
105
Travere Therapeutics
TVTX
$1.75B
| $5.16M | 0.17% |
212,869
| – | – |
|
106
Kura Oncology
KURA
$732M
| $5.12M | 0.16% |
273,463
| – | – |
|
107
Healthpeak Properties
DOC
$12.3B
| $5.04M | 0.16% |
150,392
| – | – |
|
|
ARNA
108
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $4.98M | 0.16% |
83,629
-112,756
| -57% | -$6.71M |
|
109
Align Technology
ALGN
$9.59B
| $4.96M | 0.16% |
7,459
-2,466
| -25% | -$1.64M |
|
110
Theravance Biopharma
TBPH
$691M
| $4.86M | 0.16% |
656,296
| – | – |
|
|
RCM
111
DELISTED
R1 RCM Inc. Common Stock
RCM
| $4.45M | 0.14% |
202,351
| – | – |
|
112
Fate Therapeutics
FATE
$115M
| $4.31M | 0.14% |
72,727
| – | – |
|
|
VRNA
113
Verona Pharma
VRNA
$9.18B
| $4.12M | 0.13% |
751,905
| – | – |
|
114
Zai Lab
ZLAB
$3.48B
| $3.96M | 0.13% |
37,523
| – | – |
|
|
MREO
115
Mereo BioPharma
MREO
$275M
| $3.75M | 0.12% |
1,551,082
+506,292
| +48% | +$1.23M |
|
|
116
ResMed
RMD
$39.4B
| $3.74M | 0.12% |
14,189
-123,618
| -90% | -$32.6M |
|
|
AFMD
117
DELISTED
Affimed
AFMD
| $3.62M | 0.12% |
58,604
-32,270
| -36% | -$1.99M |
|
118
Scholar Rock
SRRK
$3.3B
| $3.59M | 0.12% |
108,833
| – | – |
|
119
Medpace
MEDP
$13.5B
| $3.57M | 0.12% |
18,871
| – | – |
|
120
Vir Biotechnology
VIR
$765M
| $3.54M | 0.11% |
81,400
| – | – |
|
121
Stevanato
STVN
$6.36B
| $3.49M | 0.11% |
+137,872
| New | +$3.49M |
|
|
FMTX
122
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
| $3.47M | 0.11% |
149,825
| – | – |
|
123
Takeda Pharmaceutical
TAK
$47.8B
| $3.44M | 0.11% |
210,146
| – | – |
|
124
Steris
STE
$23.9B
| $3.41M | 0.11% |
16,669
-10,986
| -40% | -$2.24M |
|
125
Arcutis Biotherapeutics
ARQT
$1.91B
| $3.15M | 0.1% |
131,633
| – | – |
|